胰腺癌立体定向体部放疗同步整合加量与保护的计划基准研究:DEGRO/DGMP立体定向放射治疗与放射外科工作组结果
国际计划基准研究评估胰腺癌SBRT中同步整合加量(SIB)与同步整合保护(SIP)概念能否改善并统一计划质量。42家机构5个国家共生成292个计划,两阶段比较显示经集体讨论和培训后SIB/SIP专用概念可使计划质量更统一且惩罚分明显减少。
要点
- 第一阶段仅76%和74%的计划者在5次和8次分割中GTVD50%处方在2%以内。
- 第二阶段95%的计划者GTVD50%处方在2%以内,GTVD99%和OAR剂量更统一。
- 19名计划者中14名计划排名改善,其中9名至少提升2个名次。
核心结论
- 专用SIB/SIP概念结合多参数处方和约束可使胰腺癌SBRT计划质量整体统一且高。
- 经集体共识和培训后,多中心临床试验中标准化SIB/SIP治疗计划似乎可行。
研究设计与样本
- 国际治疗计划基准研究,分发3例胰腺癌患者的计划CT和轮廓。
- 两档处方剂量:GTVD50%=5×9.2Gy(46Gy)和GTVD50%=8×8.25Gy(66Gy)。
- 第一阶段用评分系统排名计划以比较GTV/PTV与OAR的权衡。
- 第二阶段对最具挑战性病例和处方重新计划,提供专用SIB和SIP轮廓用于优化。
- 42家机构5个国家共生成292个计划,使用常用治疗计划系统。
主要发现
- 5次和8次分割中仅76%和74%的计划者GTVD50%处方在2%以内。
- GTVD99%目标大多达到,约50%计划显示初始SIB/SIP样优化策略平衡OAR与靶区剂量。
- 5次和8次分割分别给出149和217个评分惩罚,提示有改善空间。
- 第二阶段95%计划者GTVD50%处方在2%以内,GTVD99%和OAR剂量更统一且评分惩罚明显减少。
- 19名计划者中14名计划排名改善,其中9名至少提升2个名次。
关键数值与推荐
- 处方剂量GTVD50%=5×9.2Gy(46Gy)和GTVD50%=8×8.25Gy(66Gy)。
- 目标剂量参数包括GTVD50%、GTVD99%、PTVD95%和PTV0.5cc。
- 第一阶段5次和8次分割分别给出149和217个评分惩罚。
- 第二阶段95%计划者GTVD50%处方在2%以内。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The proximity or overlap of planning target volume (PTV) and organs-at-risk (OARs) poses a major challenge in stereotactic body radiation therapy (SBRT) of pancreatic cancer (PACA). This international treatment planning benchmark study investigates whether simultaneous integrated boost (SIB) and simultaneous integrated protection (SIP) concepts in PACA SBRT can lead to improved and harmonized plan quality. METHODS AND MATERIALS: A multiparametric specification of desired target doses (gross target volume [GTV]D50%, GTVD99%, PTVD95%, and PTV0.5cc) with 2 prescription doses of GTVD50% = 5 × 9.2Gy (46 Gy) and GTVD50% = 8 × 8.25 Gy (66 Gy) and OAR limits were distributed with planning computed tomography and contours from 3 PACA patients. In phase 1, plans were ranked using a scoring system for comparison of trade-offs between GTV/PTV and OAR. In phase 2, replanning was performed for the most challenging case and prescription with dedicated SIB and SIP contours provided for optimization after group discussion. RESULTS: For all 3 cases and both phases combined, 292 plans were generated from 42 institutions in 5 countries using commonly available treatment planning systems. The GTVD50% prescription was performed by only 76% and 74% of planners within 2% for 5 and 8 fractions, respectively. The GTVD99% goal was mostly reached, while the balance between OAR and target dose showed initial SIB/SIP-like optimization strategies in about 50% of plans. For plan ranking, 149 and 217 score penalties were given for 5 and 8 fractions, pointing to improvement possibilities. For phase 2, the GTVD50% prescription was performed by 95% of planners within 2%, and GTVD99% as well as OAR doses were better harmonized with notable less score penalties. Fourteen of 19 planners improved their plan rank, 9 of them by at least 2 ranks. CONCLUSIONS: Dedicated SIB/SIP concepts in combination with multiparametric prescriptions and constraints can lead to overall harmonized and high treatment plan quality for PACA SBRT. Standardized SIB/SIP treatment planning in multicenter clinical trials appears feasible after group consensus and training.
引用
- Moustakis C, Blanck O, Grohmann M, et al. Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery. Int J Radiat Oncol Biol Phys. 2024. PMID: 39222825. doi:10.1016/j.ijrobp.2024.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。